Impact of Gram stain results on initial treatment selection in patients with ventilator-associated pneumonia: a prospective observation study

Impact of Gram stain results on initial treatment selection in patients with ventilator-associated pneumonia: a prospective observation study - Impact of Gram stain results on initial treatment selection in patients with ventilator-associated pneumonia: a prospective observation study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034845

Enrollment

Registered

2018-11-10

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventilator-associated pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who had a modified clinical pulmonary infection score of 5 or more and were diagnosed ventilator-associated pneumonia

Exclusion criteria

Exclusion criteria: Patients who do not want aggressive treatment Pregnant women Patients leaving ICU

Design outcomes

Primary

Measure	Time frame
The clinical response rates	—

Secondary

Measure	Time frame
1, The selected rates of anti-pseudomonal agents and anti-MRSA agents 2, The coverage rates of initial antibiotic therapies.	—

Countries

Japan

Contacts

Public ContactTakahiro Kinoshita

Osaka General Medical Centre Division of Trauma and Surgical Critical Care

ogmc.dmat.t.kinoshita@gmail.com06-6692-1201

Outcome results